CELESTICA INC (CLS.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:CLS • CA15101Q2071

419.62 CAD
+18.73 (+4.67%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CLS. CLS was compared to 14 industry peers in the Electronic Equipment, Instruments & Components industry. CLS has an excellent profitability rating, but there are some minor concerns on its financial health. CLS is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make CLS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CLS had positive earnings in the past year.
  • CLS had a positive operating cash flow in the past year.
  • CLS had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CLS had a positive operating cash flow.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS has a better Return On Assets (11.54%) than 100.00% of its industry peers.
  • CLS has a Return On Equity of 37.56%. This is amongst the best in the industry. CLS outperforms 100.00% of its industry peers.
  • The Return On Invested Capital of CLS (24.36%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.72%, CLS is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CLS has grown nicely.
  • CLS has a Operating Margin of 7.80%. This is in the better half of the industry: CLS outperforms 78.57% of its industry peers.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • CLS's Gross Margin of 12.06% is on the low side compared to the rest of the industry. CLS is outperformed by 78.57% of its industry peers.
  • In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLS is creating value.
  • There is no outstanding debt for CLS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • The Debt to FCF ratio of CLS is 1.69, which is an excellent value as it means it would take CLS, only 1.69 years of fcf income to pay off all of its debts.
  • CLS has a better Debt to FCF ratio (1.69) than 92.86% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that CLS is not too dependend on debt financing.
  • The Debt to Equity ratio of CLS (0.34) is worse than 64.29% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CLS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z N/A
ROIC/WACC2.82
WACC8.65%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that CLS should not have too much problems paying its short term obligations.
  • CLS has a Current ratio of 1.44. This is comparable to the rest of the industry: CLS outperforms 42.86% of its industry peers.
  • CLS has a Quick Ratio of 1.44. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLS has a Quick ratio (0.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.59% over the past year.
  • Measured over the past years, CLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.67% on average per year.
  • CLS shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.46%.
  • The Revenue has been growing by 16.61% on average over the past years. This is quite good.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • CLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.06% yearly.
  • The Revenue is expected to grow by 28.15% on average over the next years. This is a very strong growth
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 50.68, the valuation of CLS can be described as expensive.
  • Based on the Price/Earnings ratio, CLS is valued cheaper than 85.71% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CLS to the average of the S&P500 Index (27.93), we can say CLS is valued expensively.
  • Based on the Price/Forward Earnings ratio of 36.56, the valuation of CLS can be described as expensive.
  • Based on the Price/Forward Earnings ratio, CLS is valued cheaper than 92.86% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.77. CLS is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 50.68
Fwd PE 36.56
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLS is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CLS is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 77.07
EV/EBITDA 31.09
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • CLS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has a very decent profitability rating, which may justify a higher PE ratio.
  • CLS's earnings are expected to grow with 33.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.31
PEG (5Y)1.16
EPS Next 2Y37.93%
EPS Next 3Y33.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELESTICA INC

TSX:CLS (2/6/2026, 7:00:00 PM)

419.62

+18.73 (+4.67%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-01
Earnings (Next)04-22
Inst Owners73.66%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner ChangeN/A
Market Cap48.27B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.11
Price Target370.26 (-11.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.66%
Min EPS beat(2)2.72%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)6.92%
Min EPS beat(4)2.72%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)8.61%
EPS beat(12)12
Avg EPS beat(12)8.72%
EPS beat(16)16
Avg EPS beat(16)8.39%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)1.55%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.11%
Min Revenue beat(4)1.55%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.46%
Revenue beat(12)11
Avg Revenue beat(12)3.05%
Revenue beat(16)15
Avg Revenue beat(16)3.51%
PT rev (1m)6.5%
PT rev (3m)37.43%
EPS NQ rev (1m)10.84%
EPS NQ rev (3m)32.78%
EPS NY rev (1m)0%
EPS NY rev (3m)26.73%
Revenue NQ rev (1m)9.38%
Revenue NQ rev (3m)24.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)17.86%
Valuation
Industry RankSector Rank
PE 50.68
Fwd PE 36.56
P/S 2.85
P/FCF 77.07
P/OCF 53.56
P/B 15.94
P/tB 21.84
EV/EBITDA 31.09
EPS(TTM)8.28
EY1.97%
EPS(NY)11.48
Fwd EY2.74%
FCF(TTM)5.44
FCFY1.3%
OCF(TTM)7.83
OCFY1.87%
SpS147.2
BVpS26.33
TBVpS19.21
PEG (NY)1.31
PEG (5Y)1.16
Graham Number70.04
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z N/A
F-Score7
WACC8.65%
ROIC/WACC2.82
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year55.75%
EBIT Next 3Y35.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS.CA FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 6 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS.CA) has a profitability rating of 7 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS.CA) is 50.68 and the Price/Book (PB) ratio is 15.94.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS.CA) is 5 / 10.